Hot Products

Raddeanoside 20
Catalog No: CFN90659

Raddeanoside 20 can slightly suppress the superoxide generation induced by N-formyl-methionyl-leucyl-phenylalanine (fMLP) in a concentration dependent manner.

Raffinose
Catalog No: CFN90425

After treatment with CVGI, Raffinose family oligosaccharide was hydrolyzed effectively to yield galactose and sucrose. AA-PCD resistance in Raffinose-grown cells occurs with a decrease in both ROS production and cytochrome c release as compared to glucose-grown cells en route to AA-PCD.

Ranaconitine
Catalog No: CFN93555

Ranaconitine has cardiotoxicity.

Randaiol
Catalog No: CFN96098

Randaiol is a natural product from Magnolia hypoleuca.

Randialic acid B
Catalog No: CFN91138

Randialic acid B shows significant cell-protective effects against H2O2-induced H9c2 cardiomyocyte injury.

Rapamycin (Sirolimus)
Catalog No: CFN60038

Rapamycin (Sirolimus, AY 22989, NSC-2260804) is a specific mTOR inhibitor with IC50 of ~0.1 nM HEK293 cells.

Rapanone
Catalog No: CFN91185

Rapanone is a potential cytotoxic compound, it induced apoptosis in MCF-7 cells mediated by increased ROS production and MMP loss, respectively. Rapanone impairs mitochondrial respiration by inhibiting electron transport chain at Complex III and promotes mitochondrial dysfunction.

Raspberry ketone
Catalog No: CFN96896

Raspberry ketone prevents and improves obesity and fatty liver by increasing norepinephrine-induced lipolysis in white adipocytes, it also can increase the fatty acid oxidation and suppressed lipid accumulation in 3T3-L1 adipocytes. Raspberry ketone has anti-melanogenic activity, it could be used to treat hyperpigmentation. Raspberry ketone enhances the differentiation of C3H10T1/2 stem cells into osteoblasts, and it may promote bone formation by an action unrelated to adipocyte differentiation.

Raspberryketone glucoside
Catalog No: CFN93228

Raspberry ketone glucoside has lasting effects for the inhibition of melanogenesis and various melanogenic factors after the degradation in the skin.

RA-V
Catalog No: CFN92605

RA-V is an potential anti-angiogenic agent, exhibits anti-angiogenic activities in HUVEC and HMEC-1 cell lines with changes in function of these endothelial cells. RA-V also has anti-cancer activity, is a potential anti-metastatic agent in breast cancer, and likely acts via PI3K/AKT and NF-κB signaling pathways in both ER-positive and ER-negative breast cancer cells.